Brief: China Resources Pharmaceutical Posts HY Revenue RMB1.01 Bln For CR Boya Bio-Pharmaceutical
22/08/2025 11:30
Aug 22 (Reuters) - China Resources Pharmaceutical 3320.HK: HY REVENUE RMB1.01 BILLION FOR CR BOYA BIO-PHARMACEUTICAL CR BOYA BIO-PHARMACEUTICAL PROPOSED TO DISTRIBUTE CASH DIVIDEND OF RMB1.50 (INCLUSIVE OF TAX) FOR EVERY 10 SHARES HY NET PROFIT ATTRIBUTABLE FOR CR BOYA BIO-PHARMACEUTICAL RMB225.3 MILLION Further company coverage: 3320.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million